Cannabis Pharm ApS: Financial statements 2023
CVR: 41811269
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Cannabis Pharm ApS (CVR 41811269) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 204,602 and a net result of DKK 16,649 compared with DKK -8,698 the year before. The profit margin was 8.1%. Equity in the 2023 report amounted to DKK 13,505. The solvency ratio was 2.1%.
- Revenue
- DKK 204,602
- Gross Profit
- DKK 21,893
- Profit/Loss
- DKK 16,649
- Equity
- DKK 13,505
- Total Assets
- DKK 639,929
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 205 t. | 22 t. | 17 t. | 14 t. | - |
| 2022 | 0 | -9 t. | -9 t. | -3 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 8, 2023, ASMJ ApS is registered as an owner of Cannabis Pharm ApS.
Cannabis Pharm ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -8,698.
About Cannabis Pharm ApS
Cannabis Pharm ApS is a Danish company of the type Anpartsselskab based in Randers SØ, founded in 2020. The company is registered under the industry Engroshandel med parfumerivarer og kosmetik. The management consists of Morten Nøhr Mortensen. The company is owned by Haldsø Holding ApS and ASMJ ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 37,330 and a net result of DKK -22,748 compared with DKK 87,314 the year before. Equity in the 2025 report amounted to DKK 78,070.